Pan-Pan Liu (Panpan Liu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Peritoneal Dialysis

Diffuse Large B Cell Lymphoma

Prognostic Factors

Endoplasmic Reticulum Stress

Top Venues

Cancer medicine

Nature communications

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Yiqing Li, Peiting Zeng, Jie Xiao, Peng Huang, Pan-Pan Liu
Modulation of energy metabolism to overcome drug resistance in chronic myeloid leukemia cells through induction of autophagy. Cell death discovery 8 (1) (2022)
Qingbin Cui, Wenwen Ding, Pan-Pan Liu, Bingling Luo, Jing Yang, Wenhua Lu, Yumin Hu, Peng Huang, Shijun Wen
Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells. International journal of molecular sciences 23 (20) (2022)
Yuchen Zhang, Pan-Pan Liu, Jun Cai, Hongmei Jing, Liqun Zou, Huiqiang Huang, Yuanbin Wu, Wenyu Li, Liye Zhong, Xueli Jin, Xu Ye, Ru Feng, Huilai Zhang, Liling Zhang, Lie Lin, Xiuhua Sun, Yuyang Tian, Zhongjun Xia, Zhi-Ming Li, He Huang, Yi Xia, Qing-Qing Cai
Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study. Cancer medicine 11 (22) (2022)
Yu-Chen Zhang, Jin-Ni Wang, Shu-Yun Ma, Jun Cai, Ning Su, Hui-Qiang Huang, Zhi-Ming Li, Zhong-Jun Xia, He Huang, Pan-Pan Liu, Yi Xia, Qing-Qing Cai
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma. British journal of haematology (2021)
Yi Xia, Silan Huang, Yu Wang, Dexin Lei, Yanlou Wang, Hang Yang, Yan Gao, Pan-Pan Liu
Prognostication of Primary Tumor Location in Early-Stage Nodal Diffuse Large B-Cell Lymphoma: An Analysis of the SEER Database. Cancers 13 (16) (2021)
Yuchen Zhang, Shuyun Ma, Jun Cai, Yu Yang, Hong-Mei Jing, Yuerong Shuang, Zhigang Peng, Bingzong Li, Pan-Pan Liu, Zhongjun Xia, Yi Xia, Yan Gao, Daoguang Chen, Jianyang Lin, Qihui Li, Shenghua Xu, Qingyuan Xu, Han Zhang, Huiqiang Huang, Qing-Qing Cai
Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer/T-cell lymphoma: A multicenter study. American journal of hematology 96 (11) (2021)
Cui Chen, Peng Sun, Juan Cui, Shumei Yan, Hao Chen, Yi Xia, Xiwen Bi, Pan-Pan Liu, Yu Wang, Hang Yang, Man Nie, Xue-Wen Zhang, Wenqi Jiang, Zhi-Ming Li
High-dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China. Cancer medicine 8 (4) (2019)
Ze-Long Liu, Pan-Pan Liu, Xi-Wen Bi, De-Xin Lei, Yu Wang, Zhi-Ming Li, Wen-Qi Jiang, Yi Xia
Trends in survival of patients with stage I/II Burkitt lymphoma in the United States: A SEER database analysis. Cancer medicine 8 (3) (2019)
Ze-Long Liu, Xi-Wen Bi, Pan-Pan Liu, De-Xin Lei, Wen-Qi Jiang, Yi Xia
The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis. Disease markers 2018 (2018)
Pan-Pan Liu, Ke-Feng Wang, Jie-Tian Jin, Xi-Wen Bi, Peng Sun, Yu Wang, Hang Yang, Zhi-Ming Li, Wen-Qi Jiang, Yi Xia
Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis. Cancer medicine 7 (5) (2018)
Pan-Pan Liu, Yi Xia, Xi-Wen Bi, Yu Wang, Peng Sun, Hang Yang, Zhi-Ming Li, Wen-Qi Jiang
Trends in Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: An Analysis of 7051 Cases in the SEER Database. Disease markers 2018 (2018)